Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Amrize (AMRZ) Cost of Revenue (2024 - 2025)

Amrize (AMRZ) has disclosed Cost of Revenue for 2 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • Quarterly Cost of Revenue changed 0.34% to $2.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $8.8 billion for FY2025, 1.7% up from the prior year.
  • Cost of Revenue hit $2.1 billion in Q4 2025 for Amrize, down from $2.6 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.6 billion in Q3 2025 to a low of $2.1 billion in Q4 2024.